Password reminder
No account yet? Register Free
About Us Advertising Info Contact Us Client Login
biotechdaily.com
Features Subscription Partner Sites Journal Info
GLOBETECH PUBLISHINGSANYO EUROPE LTDROCHE APPLIED SCIENCE

Metalloproteinase Inhibitors May Be Useful in Huntington's Disease

By BiotechDaily International staff writers
Posted on 17 Aug 2010


A group of metalloproteinases has been identified as a potential target for drugs to treat Huntington's disease (HD), a chronic and eventually fatal hereditary neurological disorder.

Huntington's disease is caused by a dominant gene that encodes a protein known as huntingtin. The 5' end of the HD gene has a sequence of three DNA bases, cytosine-adenine-guanine (CAG), coding for the amino acid glutamine, that is repeated multiple times. Normal persons have a CAG repeat count of between seven and 35 repeats, while the mutated form of the gene has anywhere from 36 to 180 repeats. The mutant form of huntingtin is broken down into toxic peptides, which contribute to the pathology of the syndrome.

Previous studies on the breakdown of huntingtin focused on the protease families known as caspases and calpains. In a recent study published in July 29, 2010, issue of the journal Neuron investigators at the Buck Institute for Age Research (Novato, CA, USA) concentrated on a different group of proteolytic enzymes, the matrix metalloproteinases (MMPs).

They used a high-throughput western blot-based screen to examine 514 siRNAs targeting the repertoire of human protease genes. This screen identified 11 proteases that, when inhibited, reduced huntingtin fragment accumulation. Three of these proteases belonged to the matrix metalloproteinase (MMP) family. One family member, MMP-10, directly cleaved huntingtin and prevented cell death when knocked down in a neuron cell culture. Correspondingly, MMPs were found to be activated in HD mouse models.

"We have found a target that has known drugs for cancer treatment that could possibly have significance for HD,” said senior author Dr. Lisa Ellerby, a senior researcher at the Buck Institute for Age Research. "MMPs are also involved in stroke, inflammation, and many neurological processes; we expect a lot of scientific attention to now be focused on this important class of proteases. The next step in this research will be to test some of the MMP inhibitor drugs as a potential treatment in HD mouse models. We will also be crossing mice that no longer have particular MMPs with those who have HD to see what effect that has on offspring.”

Related Links:

Buck Institute for Age Research





Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to BiotechDaily.com and get complete access to news and events that shape the world of biotechnology.
Free digital version edition of Bio Research International sent by email on regular basis
Free print version of Bio Research International magazine
(available only outside USA and Canada).
Free and unlimited access to back issues of Bio Research International in digital format
Free Bio Research International Newsletter sent every 2 weeks containing the latest news
Free breaking news sent via email
Free access to Events Calendar
Free access to LinkXpress new product services
REGISTRATION IS FREE AND EASY!


Click here to Register

Sign in: Registered website members
Username: Password:
Forgot username/password? Click here!
Sign in: Registered magazine subscribers
Subcode: Last Name:
What is SUBCODE?




SPE Workstation
SPE Workstation
Atomizing Nozzles
Atomizing Nozzles
Parallel Bioreactor
Parallel Bioreactor

More Products

Latest Drug Discovery News

LinkXpress
Click for LinkXpress
Reader Inquiry Service
Enter code to receive information:
Where I can find code?
Featured Video
BioTek:
The Race

View Video
Featured Whitepaper
ELGA LABWATER:
Why pure water is important in modern chromatography

Download Whitepaper
Events
ArabLab 2012
16 Mar 2012
29 Mar 2012


BIO Tech 2012 - BIO Forum Expo Japan.
09 May 2012
11 May 2012


ELA 2012 - European Lab Automation.
30 May 2012
31 May 2012


More events
Latest Issue

View Digital Edition
Subscribe / Renew
HTL Lab Solutions
SLAS - Society for Laboratory Automation and Screening
VISION-SCIENCES, INC.
  biotechdaily.com Copyright © 2000-2012 Globetech Media. All rights reserved.
Privacy Policy